RAGHX Mutual Fund

RAGHX Mutual Fund

NAV$31.29
See how much of RAGHX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
$91M
Expense Ratio
1.40%
Dividend Yield (Current)
-
Holdings
24
Inception Date
Feb 5, 2002
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD-0.47%
1 Year+16.03%
3 Year+1.70%
5 Year-0.05%
10 Year+6.77%

Asset Allocation

Stocks: 100.00%
See how much of RAGHX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.13.30%
MCKMckesson Corp Common Stock USD 0.015.57%
ABBVAbbvie Inc.5.09%
VRTXNvaesrtex Pharmaceuticals Inc5.09%
MRKMerck & Company Inc5.05%
Top 10 Concentration: 55.84%Report Date: Mar 31, 2026
Download all 24 holdings for RAGHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$7.49
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

RAGHX Mutual Fund Overview

RAGHX Mutual Fund (Virtus KAR Health Sciences Fund Class A) is managed by Virtus Investment Partners with $91.1M in net assets. RAGHX expense ratio is 1.40%, holding 24 positions across sectors including Health Care, Consumer Staples. Inception date: 2002-02-05.

RAGHX performance shows a YTD return of -0.47%. The 1-year return is 16.03% and the 5-year return is -0.05%.

RAGHX top holdings include Eli Lilly & Co. (13.3%), Mckesson Corp Common Stock USD 0.01 (5.6%), Abbvie Inc. (5.1%), Nvaesrtex Pharmaceuticals Inc (5.1%), Merck & Company Inc (5.0%). Go to all RAGHX holdings, RAGHX sectors, or RAGHX dividends.

RAGHX can be compared against other funds. Use RAGHX overlap to find shared positions, or RAGHX vs another fund for a side-by-side view. RAGHX alternatives are available via the screener, along with tax-loss harvesting opportunities.